Career Development Program

职业发展计划

• 批准号: 8541584
• 负责人: ELIZABETH A GRIMM
• 金额: $ 14.2万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-09 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8541584
• 关键词: Academic Training; Advisory Committees; Area; Award; Basic Science; Behavioral; Biochemistry; Bioethics; Biological; Biology; Budgets; Cancer Biology; Clinical; Clinical Investigator; Clinical Research; Clinical trial protocol document; Commit; Cutaneous Melanoma; Data; Decision Making; Doctor of Medicine; Doctor of Philosophy; Educational Status; Educational process of instructing; Environment; Etiology; Faculty; Fellowship; Funding; Future; Genetic Predisposition to Disease; Goals; Grant; Heterogeneity; Human; Human Genetics; Immunology; Individual; Interdisciplinary Study; Intervention; K-Series Research Career Programs; Knowledge; Laboratories; Laboratory Scientists; Learning; Mentors; Mentorship; Metastatic Melanoma; Molecular; Molecular Biology; Neoplasm Metastasis; Patients; Persons; Physicians; Postdoctoral Fellow; Process; Publications; Qualifying; Recruitment Activity; Research; Research Personnel; Research Priority; Scientist; Senior Scientist; Skin Cancer; Training; Translational Research; University of Texas M D Anderson Cancer Center; Work; base; career development; design; experience; high standard; improved; innovation; meetings; melanoma; member; professor; programs; success

The goal of the Melanoma SPORE Career Development Program (CDP) is to develop an integrated cadre of investigators at all levels of training dedicated to translational research on human melanoma. We have successfully accomplished this goal over the past 4.5 years of this SPORE through our funding and training of ten CDP recipients who are now supporting their melanoma research through 1 R01,1 CIDR, 2 R21s, and one MDACC Institutional grant on melanoma. In addition they have generated a substantial quantity of new data and information resulting in 20 publications. We will continue this program and aim to (1) recruit junior and senior physicians and basic laboratory scientists and support them to become competent translational investigators in the study of melanoma, (2) provide in-depth training in translational science principles of human cancer biology not commonly included in clinical fellowship training or Ph.D. programs, and (3) teach the fundamentals of the biology and clinical course of human melanoma to improve the ability of the awardees to conduct innovative translational research. The unique educational environment at M.D. Anderson and in the M.D. Anderson Melanoma Multidisciplinary Research Program has and will continue to assure that these goals are met. Up to three career development trainees (preferably 2 faculty members and 1 post doctoral fellow) will be supported annually. A portion of the NCl SPORE budget ($75,000 per year) plus half of the institutional commitment funds ($100,000 for the CDP per year) provided by the M.D. Anderson is available to the SPORE, resulting in $175,000 each year to Support the CDP in Melanoma. Solicitations will be made yearly for qualified candidates from within and outside of M.D. Anderson. The awardees will be reviewed and ranked by the SPORE Executive Committee and Internal Advisory Committee, with final decision made by the External Advisory Committee. A second year of support will also be available contingent upon review by the Internal Advisory Committee. Our mentorship program includes nationally recognized clinical and translational investigators who provide comprehensive training. Their success is evident in the accomplishments of the group of scientists awarded CDP awards over the last 4.5 year. Two of these individuals are now full contributors of this SPORE serving as Co-Leaders of projects. We propose to continue the high standards we have established and evaluate our program annually. We will modify our selection and training processes as required allowing us to continue to train future scientist in translational research on human melanoma throughout the term of this SPORE.

黑色素瘤孢子职业发展计划（CDP）的目的是在各种培训中开发一个专门用于人类黑色素瘤转化研究的培训的研究人员。在过去的4。5年中，我们通过10个CDP接收者的资金和培训成功实现了这一目标，他们现在通过1 R01,1 CIDR（2 R21）支持其黑色素瘤研究， 以及一项关于黑色素瘤的MDACC机构赠款。此外，它们还产生了大量新数据和信息，从而产生了20个出版物。我们将继续该计划，并旨在（1）招募初级和高级医师以及基本实验室科学家，并支持他们成为黑色素瘤研究中有能力的翻译调查员，（2）提供转化科学的深入培训。 人类癌症生物学的原理不常见于临床研究金培训或博士学位。计划，以及（3）教授人类黑色素瘤生物学和临床过程的基础知识，以提高获奖者进行创新转化研究的能力。医学博士独特的教育环境 安德森（Anderson）和医学博士（M.D. Anderson Melanoma）多学科研究计划并将继续确保实现这些目标。每年将支持多达三名职业发展学员（最好是2名教职员工和1名博士后研究员）。 NCL孢子预算的一部分（每年75,000美元） 加上M.D. Anderson提供的机构承诺基金的一半（每年为100,000美元的CDP）提供给孢子，每年为175,000美元提供支持黑色素瘤的CDP。 招标将每年针对M.D. Anderson内外的合格候选人进行。由孢子执行委员会和内部咨询委员会对获奖者进行审查和排名，并由外部咨询委员会做出最终决定。内部咨询委员会的审查也将获得第二年的支持。我们的指导计划包括 全国认可的临床和转化调查人员提供全面的培训。在过去的4。5年中，科学家小组颁发了CDP奖项的成就，他们的成功是显而易见的。现在，其中两个人是该孢子的全部贡献者，是项目的共同领导者。 我们建议继续每年建立并评估我们的计划的高标准。我们将根据需要修改我们的选择和培训过程，使我们能够在整个孢子的整个学期中继续培训有关人类黑色素瘤的翻译研究。